Delhi Court acquits Arvind Kejriwal, Manish Sisodia and Yogendra Yadav in defamation case

New Delhi: The Rouse Avenue Court on Saturday acquitted Delhi Chief Minister Arvind Kejriwal, his Deputy Manish Sisodia and former AAP leader Yogendra Yadav in a criminal defamation case filed by lawyer Surender Sharma,in relation to 2013 assemby elections. Surender Sharma claimed that his candidature from AAP was cancelled in 2013 assembly elections at last moment. The Additional Chief Metropolitan Magistrate (ACMM) Vidhi Gupta on Saturday while passing the order said the media articles cited by the complainant has been perused, however, the complainant could not establish a case of defamation from these reports. All three persons were present in the court while the order was pronounced by the court on Saturday. The case was filed by one lawyer Surender Kumar Sharma who died due to ill health during the case hearing. Later his nephew continues to pursue the case in court. According to Sharma, he had filed a defamation complaint against these leaders and pleaded that his candidature from AAP was cancelled in 2013 and published in various newspapers in a defamatory manner. Surender Kumar Sharma, in his complaint, had alleged that in 2013 he was approached by several volunteers of AAP just before the election, who had asked him to contest the Delhi Assembly elections on Aam Aadmi Party ticket, saying Arvind Kejriwal was pleased with his social services. He later decided to fill up the application form to contest the election after being told by Manish Sisodia and Yogendra Yadav that AAP’s Political Affairs Committee had decided to give him the ticket. However, it was later denied to him. On 14 October 2013, the complainant Surender Kumar Sharma claimed that articles in various leading newspapers carried “defamatory, unlawful and derogatory words used by these political persons which have lowered his reputation in the society. Read all the Latest News , Trending News ,  Cricket News , Bollywood News , India News and Entertainment News here. Follow us on Facebook, Twitter and Instagram.